Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-11-28 | Reverse | 1:25 |
| 2022-06-28 | Reverse | 1:60 |
ProMIS Neurosciences develops precision medicine therapies targeting misfolded proteins in neurodegenerative diseases like Alzheimer's, ALS, and MSA, using proprietary algorithms to identify novel therapeutic targets.

A clinical-stage antibody therapy targeting and neutralizing toxic amyloid-beta oligomers to potentially provide a precise and safer treatment for Alzheimer's disease.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
ANL | $13.70 | COMPARE |
MPLT | $11.21 | COMPARE |
EDSA | $4.43 | COMPARE |
LPCN | $2.09 | COMPARE |
OSRH | $0.28 | COMPARE |
BRTX | $0.22 | COMPARE |
GOVX | $0.65 | COMPARE |
ERNA | $4.86 | COMPARE |